Transcript
  • (immunomodulator)

    immunosupressive agents immunopotentiating agents / immnuoadjuvants (immunonormalizing agents) (immunosubstituting agents)

  • innate immune response/adaptive immune responseBT

  • 1. hypersensitivity2. autoimmune diseasessystemic lupus erythematosus1type 1 diabetes mellitus3. immunoproliferative diseasemultiple myeloma

  • 4. immunodeficiency diseaseHIVsolid tumorshematological malignanciesinfectious diseases5. graft rejection6. tumor

  • 1 2 3/

  • 1.immunosuppressive agents2.3.4.24~48h5.

  • /

  • 1. 2. 3. /4. 5.

  • TTIL-1IL-2IL-6-GREnGRE-IBNFB

  • calcineurinTFK506-FKBPTNFATIL-2TIL-2FKBPmTOR

  • cyclosporinCsATIL-1-transforming growth factor-TGF-cyclophilincalcineurinT(nuclear factor of activated T cellsNFAT)NFAT

  • ( systemic lupus erythematosusSLE)(lupus nephritisLN)(myelodysplastic syndromeMDS)(nephrotic syndromeNS)

  • B

  • tacrolimusFK506FK506FKBPNFATTFK506G0ATCD3IL-2FK506Ca2+TBTB

  • -FK506FK506

  • mycophenolate mofetilMMF MMFMPAMPAinosine monophosphate dehydrogenaseIMPDHde novo synthesis pathwaysalvage pathwayIMPDHMPAIMPDH4~5TBIMPDHMPA

  • MMFIgA

  • MMFMPAMPAGMMFMPAMPA

  • ATG

  • ATGTCD2. CD3. CD4. CD8CD11aCD18CD25CD44CD45TBT

  • Aza10%~15%TATG

  • -CD3 (Muromonab-CD3)-CD3TCD3TTT

  • tripterygium glycosidesIL-2

  • immunopotentiating agents

  • 1 Q102 3 NPT-15392poly ICpoly AU4 5 PHAAConA

  • 1 -2. AIDSataxia-telangiectasia syndrome2 3

  • (bacillus calmette-guerin vaccine ,BCG) TBNKBCGBCG BCG

  • levamisoleLMS LMST/TEPHAcAMPTIL-2

  • LMSLMSLMS

  • -2 aldesleukin IL-2IL-2IL-2ThTcNKBIL-2IL-1

  • interferonIFN-NKIFNIFNKaposi

  • transfer factorTFTFRNAreverse transcriptaseTFDNATFTTFIgG

  • 1 thymosin 1T1 T1TT1TdTIFNIL-2IL-2IFN- HBsAgHBeAgT1CD3CD4HBVIFN-T1

  • 1.2. 3.4.5.-CD3

  • /

    immnuoadjuvants (immunonormalizing agents) (immunosubstituting agents)1.

  • 1.immunosuppressive agents2.3.4.24~48h5.2.

  • 3.

    /

  • 4. TIL-1-transforming growth factor-TGF-cyclophilincalcineurinT(nuclear factor of activated T cellsNFAT)NFAT

  • 5.-CD3

    -CD3TCD3TT


Recommended